VOR vs. VT
VOR (Vor Biopharma Inc.) is a stock, while VT (Vanguard Total World Stock ETF) is Global Equities fund tracking the FTSE Global All Cap Index. Over the past 5 years, VOR returned -43.96%/yr vs 10.87%/yr for VT. At a 0.27 correlation, their price movements are largely independent.
Performance
VOR vs. VT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VOR achieves a 32.57% return, which is significantly higher than VT's 11.34% return.
VOR
- 1D
- -4.09%
- 1M
- 22.89%
- 6M
- 23.33%
- YTD
- 32.57%
- 1Y
- -59.10%
- 3Y*
- -33.13%
- 5Y*
- -43.96%
- 10Y*
- —
VT
- 1D
- -0.74%
- 1M
- -0.82%
- 6M
- 8.37%
- YTD
- 11.34%
- 1Y
- 22.85%
- 3Y*
- 18.61%
- 5Y*
- 10.87%
- 10Y*
- 12.39%
VOR vs. VT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
VOR Vor Biopharma Inc. | 32.57% | -41.08% | -50.67% | -66.17% | -42.77% | -72.35% |
VT Vanguard Total World Stock ETF | 11.34% | 22.43% | 16.49% | 22.02% | -18.00% | 13.98% |
Correlation
The correlation between VOR and VT is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Feb 5, 2021 | 0.27 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VOR vs. VT — Risk / Return Rank
VOR
VT
VOR vs. VT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vor Biopharma Inc. (VOR) and Vanguard Total World Stock ETF (VT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VOR | VT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.19 | ||
| Sortino ratioReturn per unit of downside risk | -2.57 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 1.30 | -0.33 |
| Calmar ratioReturn relative to maximum drawdown | -0.69 | 2.37 | -3.06 |
| Martin ratioReturn relative to average drawdown | -0.97 | 10.09 | -11.06 |
Loading charts...
Drawdowns
VOR vs. VT - Drawdown Comparison
The maximum VOR drawdown since its inception was -99.72%, which is greater than VT's maximum drawdown of -50.27%. Use the drawdown chart below to compare losses from any high point for VOR and VT.
Loading charts...
Drawdown Indicators
| VOR | VT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.72% | -50.27% | -49.45% |
Max Drawdown (1Y)Largest decline over 1 year | -85.92% | -9.67% | -76.25% |
Max Drawdown (3Y)Largest decline over 3 years | -95.48% | -16.51% | -78.97% |
Max Drawdown (5Y)Largest decline over 5 years | -99.16% | -26.38% | -72.78% |
Max Drawdown (10Y)Largest decline over 10 years | — | -34.24% | — |
Current DrawdownCurrent decline from peak | -98.40% | -1.67% | -96.73% |
Average DrawdownAverage peak-to-trough decline | -88.85% | -6.98% | -81.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 60.99% | 2.27% | +58.72% |
Volatility
VOR vs. VT - Volatility Comparison
Vor Biopharma Inc. (VOR) has a higher volatility of 23.82% compared to Vanguard Total World Stock ETF (VT) at 3.93%. This indicates that VOR's price experiences larger fluctuations and is considered to be riskier than VT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VOR | VT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.82% | 3.93% | +19.89% |
Volatility (6M)Calculated over the trailing 6-month period | 59.09% | 11.49% | +47.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 116.14% | 13.67% | +102.47% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 116.52% | 16.20% | +100.32% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 116.28% | 17.16% | +99.12% |
Dividends
VOR vs. VT - Dividend Comparison
VOR has not paid dividends to shareholders, while VT's dividend yield for the trailing twelve months is around 1.59%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VOR Vor Biopharma Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VT Vanguard Total World Stock ETF | 1.59% | 1.82% | 1.95% | 2.08% | 2.20% | 1.82% | 1.66% | 2.32% | 2.53% | 2.11% | 2.39% | 2.45% |
Frequently Asked Questions
VOR and VT have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VOR has higher volatility (23.82%) compared to VT (3.93%). In terms of maximum drawdown, VOR dropped -99.72% vs VT's -50.27%.
VT currently has the higher Sharpe Ratio (1.68 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VOR and VT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer